El 21st Century Cures Act que firmó el presidente Barack Obama el martes 13 de diciembre es un éxito legislativo para la industria farmacéutica. Qué podría pasar con los servicios de medicina preventiva.
A breakdown of winners — and a few losers — in the sprawling Cures Act approved by the House.
The legislation would give federal officials more flexibility in evaluating the effectiveness and safety of drugs and devices and add billions of dollars to NIH funding. But critics say it could endanger patients’ safety and doesn’t do enough to stop spiraling drug prices.
Federal officials have released final regulations for the new program, which will reward physicians for providing high quality, efficient care.
The government is laying out plans to use payment incentives to promote higher quality care, but physicians say the new system may be hard on solo practices and small groups.